Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Pruritus, Rash, Vaccination site pain
Clinical narrative: Injected limb mobility decreased; Itchiness; Her arm was also sore later that night at the injection site; Getting a rash almost immediately, from her shoulder to her elbow/ Rash spread from bottom of bra area, to her belly button area, then lower to her waist, & the scalp on the right side; This spontaneous case was reported by a consumer and describes the occurrence of INJECTED LIMB MOBILITY DECREASED (Injected limb mobility decreased), PRURITUS (Itchiness), RASH (Getting a rash almost immediately, from her shoulder to her elbow/ Rash spread from bottom of bra area, to her belly button area, then lower to her waist, & the scalp on the right side) and VACCINATION SITE PAIN (Her arm was also sore later that night at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 013A21A) for COVID-19 vaccination.     The patient's past medical history included Hysterectomy. Concurrent medical conditions included Sensitive skin. Concomitant products included OXYCODONE for Neck pain and Back pain, METFORMIN, LISINOPRIL, ESTROGENS CONJUGATED (PREMARIN) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 02-Apr-2021, the patient experienced RASH (Getting a rash almost immediately, from her shoulder to her elbow/ Rash spread from bottom of bra area, to her belly button area, then lower to her waist, & the scalp on the right side). On 03-Apr-2021, the patient experienced INJECTED LIMB MOBILITY DECREASED (Injected limb mobility decreased), PRURITUS (Itchiness) and VACCINATION SITE PAIN (Her arm was also sore later that night at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy, at a dose of UNK dosage form and CORTISONE for Allergy, at a dose of UNK dosage form. At the time of the report, INJECTED LIMB MOBILITY DECREASED (Injected limb mobility decreased), PRURITUS (Itchiness), RASH (Getting a rash almost immediately, from her shoulder to her elbow/ Rash spread from bottom of bra area, to her belly button area, then lower to her waist, & the scalp on the right side) and VACCINATION SITE PAIN (Her arm was also sore later that night at the injection site) outcome was unknown.            The patient was advised to stop Benadryl (diphenhydramine HCL) and use Cortisone 10 (hydrocortisone) as treatment of the events. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-100469, MOD-2021-100469 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30-Apr-2021: event itchiness was updated. On 01-Jun-2021: Follow up received on 01-Jun-2021  contains no new information. On 04-Jun-2021: Follow up received on 04-JUN-2021: Non-significant follow up appended